CN102558340B - 一种glp-1衍生物 - Google Patents
一种glp-1衍生物 Download PDFInfo
- Publication number
- CN102558340B CN102558340B CN2012100131244A CN201210013124A CN102558340B CN 102558340 B CN102558340 B CN 102558340B CN 2012100131244 A CN2012100131244 A CN 2012100131244A CN 201210013124 A CN201210013124 A CN 201210013124A CN 102558340 B CN102558340 B CN 102558340B
- Authority
- CN
- China
- Prior art keywords
- fmoc
- glp
- derivative
- ala
- gly
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012100131244A CN102558340B (zh) | 2009-01-12 | 2009-01-12 | 一种glp-1衍生物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012100131244A CN102558340B (zh) | 2009-01-12 | 2009-01-12 | 一种glp-1衍生物 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009100451880A Division CN101463081B (zh) | 2009-01-12 | 2009-01-12 | 一种glp-1衍生物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102558340A CN102558340A (zh) | 2012-07-11 |
CN102558340B true CN102558340B (zh) | 2013-07-17 |
Family
ID=46405069
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2012100131244A Active CN102558340B (zh) | 2009-01-12 | 2009-01-12 | 一种glp-1衍生物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102558340B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20210125028A (ko) * | 2019-02-06 | 2021-10-15 | 엔진 바이오사이언스 리미티드 | 글루카곤-유사 펩타이드-1(glp-1) 작용제 유사체, 이의 제조 방법 및 용도 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5545618A (en) * | 1990-01-24 | 1996-08-13 | Buckley; Douglas I. | GLP-1 analogs useful for diabetes treatment |
CN1982336A (zh) * | 2006-03-03 | 2007-06-20 | 华东师范大学 | 一种人胰高血糖素样肽-1衍生物及其制备和应用 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2222613T3 (es) * | 1997-09-12 | 2005-02-01 | Pharis Biotec Gmbh | Composicion para la terapia de diabetes mellitus y de la obesidad. |
-
2009
- 2009-01-12 CN CN2012100131244A patent/CN102558340B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5545618A (en) * | 1990-01-24 | 1996-08-13 | Buckley; Douglas I. | GLP-1 analogs useful for diabetes treatment |
CN1982336A (zh) * | 2006-03-03 | 2007-06-20 | 华东师范大学 | 一种人胰高血糖素样肽-1衍生物及其制备和应用 |
Non-Patent Citations (9)
Title |
---|
A synthetic glucagon-like peptide-1 analog with improved plasma stability;U Ritzel et al.;《Journal of Endocrinology》;19981231(第159期);第93-102页 * |
CAROLYN F. DEACON et al..Degradation of Endogenous and Exogenous Gastric Inhibitory Polypeptide in Healthy and in Type 2 Diabetic Subjects as Revealed Using a New Assay for the Intact Peptide.《The Journal of Clinical Endocrinology & Metabolism》.2000,第85卷(第10期),第3575-3581页. |
CAROLYN F. DEACON et al..Degradation of Endogenous and Exogenous Gastric Inhibitory Polypeptide in Healthy and in Type 2 Diabetic Subjects as Revealed Using a New Assay for the Intact Peptide.《The Journal of Clinical Endocrinology & * |
H.Agerso et al..The pharmacokinetic,pharmacodynamics,safety and tolerability of NN2211,a new long-acting GLP-1 derivative,in healthy men.《Diabetologia》.2002,第45卷第195-202页. |
Long-Lasting Antidiabetic Effect of a Dipeptidyl Peptidase IV-Resistant Analog of Glucagon-Like Peptide-1;Remy Burcelin et al.;《Metabolism》;19990228;第48卷(第2期);第252-258页 * |
Metabolism》.2000,第85卷(第10期),第3575-3581页. * |
Remy Burcelin et al..Long-Lasting Antidiabetic Effect of a Dipeptidyl Peptidase IV-Resistant Analog of Glucagon-Like Peptide-1.《Metabolism》.1999,第48卷(第2期),第252-258页. |
The pharmacokinetic,pharmacodynamics,safety and tolerability of NN2211,a new long-acting GLP-1 derivative,in healthy men;H.Agerso et al.;《Diabetologia》;20021231;第45卷;第195-202页 * |
U Ritzel et al..A synthetic glucagon-like peptide-1 analog with improved plasma stability.《Journal of Endocrinology》.1998,(第159期),第93-102页. |
Also Published As
Publication number | Publication date |
---|---|
CN102558340A (zh) | 2012-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101463081B (zh) | 一种glp-1衍生物 | |
CN102532301B (zh) | 一类新型的Exendin-4类似物及其制备方法 | |
KR101087859B1 (ko) | 인슐린친화성 펩타이드 합성법 | |
CN101993485B (zh) | 促胰岛素分泌肽类似物同源二聚体及其用途 | |
CN111410686B (zh) | Glp-1r激活剂的分子改构及其二聚体在治疗代谢病中的应用 | |
KR101297942B1 (ko) | 글루카곤형 펩티드의 합성 | |
AU2012237899B2 (en) | Site-directed mono-substituted PEGylated Exendin analog and preparation method therefor | |
CN108271356A (zh) | 肠降血糖素-胰岛素缀合物 | |
JPH11502204A (ja) | 親油性のペプチドホルモン誘導体 | |
CN106029088A (zh) | 稳定的胰高血糖素类似物以及用于治疗低血糖的用途 | |
CN103224558B (zh) | 一种艾塞那肽的制备方法 | |
CN101463078B (zh) | 一种Exendin-4衍生物及其固相化学合成 | |
CN113135991B (zh) | 一种制备索玛鲁肽的方法 | |
CN110317258A (zh) | 一种索玛鲁肽的新多肽片段及其制备方法 | |
CN106866788B (zh) | 醋酸奥曲肽制备和醋酸奥曲肽注射液药物组合物 | |
CN101747426A (zh) | 一种合成普兰林肽的方法 | |
CN109432394B (zh) | 醋酸奥曲肽注射液药物组合物及其用途 | |
CN103265630B (zh) | 艾塞那肽的制备方法 | |
CN113429471B (zh) | 长效glp-1多肽类似物及其制备方法和应用 | |
CN1904150B (zh) | 一种人胰高血糖素样肽-1衍生物及其固相化学合成 | |
CN106860854B (zh) | 醋酸奥曲肽注射液药物组合物和醋酸奥曲肽 | |
CN102558340B (zh) | 一种glp-1衍生物 | |
CN108070030B (zh) | 洛塞那肽及其类似物的制备方法 | |
CN102558339B (zh) | 一种glp-1衍生物 | |
CN111944037B (zh) | 一种索玛鲁肽的合成方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: WANG RONGFANG QIAN ZHENBIN SUN HAO Effective date: 20131118 Owner name: WU JUN Free format text: FORMER OWNER: EAST CHINA NORMAL UNIVERSITY Effective date: 20131118 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 200062 PUTUO, SHANGHAI TO: 200031 XUHUI, SHANGHAI |
|
TR01 | Transfer of patent right |
Effective date of registration: 20131118 Address after: 200031 room 299, South Urumqi Road, Shanghai, 2604 Patentee after: Wu Jun Patentee after: Wang Rongfang Patentee after: Qian Zhenbin Patentee after: Sun Hao Address before: 200062 Putuo District, Zhongshan North Road, No. 3663, Patentee before: East China Normal University |
|
ASS | Succession or assignment of patent right |
Free format text: FORMER OWNER: WANG RONGFANG QIAN ZHENBIN SUN HAO Effective date: 20140526 Owner name: TIANJIN BINHAIXIN HAIJIN JIUHE PHARMACEUTICAL TECH Free format text: FORMER OWNER: WU JUN Effective date: 20140526 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 200031 XUHUI, SHANGHAI TO: 300457 BINHAI NEW DISTRICT, TIANJIN |
|
TR01 | Transfer of patent right |
Effective date of registration: 20140526 Address after: 300457, Tianjin Binhai New Area Lingang Economic Zone, Bohai twelve South Road, Lingang Pioneer Park, Bl building, 4 floor Patentee after: Tianjin Binhai New Area Hai long long and Pharmaceutical Technology Co., Ltd. Address before: 200031 room 299, South Urumqi Road, Shanghai, 2604 Patentee before: Wu Jun Patentee before: Wang Rongfang Patentee before: Qian Zhenbin Patentee before: Sun Hao |
|
ASS | Succession or assignment of patent right |
Owner name: TIANJIN HAIJIN JIUHE BIOLOGICAL TECHNOLOGY CO., LT Free format text: FORMER OWNER: TIANJIN BINHAIXIN HAIJIN JIUHE PHARMACEUTICAL TECHNOLOGY CO., LTD. Effective date: 20150106 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 300457 BINHAI NEW DISTRICT, TIANJIN TO: 300457 HANGU, TIANJIN |
|
TR01 | Transfer of patent right |
Effective date of registration: 20150106 Address after: 300457 Tianjin Development Zone, No. 220 Dongting Road, Tianjin International Institute of biomedical research laboratory building, layer N1411, fourteen Patentee after: TIANJIN HAIJIN JIUHE BIOLOGICAL TECHNOLOGY CO., LTD. Address before: 300457, Tianjin Binhai New Area Lingang Economic Zone, Bohai twelve South Road, Lingang Pioneer Park, Bl building, 4 floor Patentee before: Tianjin Binhai New Area Hai long long and Pharmaceutical Technology Co., Ltd. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20170321 Address after: 200120 Shanghai city Pudong New Area Tianxiong road 588 Lane Shanghai International Medical Park Business Park Building No. 16 Patentee after: DiaSys Diagnostic Systems (Shanghai) Co., Ltd. Address before: 300457 Tianjin Development Zone, No. 220 Dongting Road, Tianjin International Institute of biomedical research laboratory building, layer N1411, fourteen Patentee before: TIANJIN HAIJIN JIUHE BIOLOGICAL TECHNOLOGY CO., LTD. |
|
TR01 | Transfer of patent right |